These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9664907)

  • 21. Substantial production of ghrelin by a human medullary thyroid carcinoma cell line.
    Kanamoto N; Akamizu T; Hosoda H; Hataya Y; Ariyasu H; Takaya K; Hosoda K; Saijo M; Moriyama K; Shimatsu A; Kojima M; Kangawa K; Nakao K
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4984-90. PubMed ID: 11600575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma.
    Zatelli MC; Tagliati F; Amodio V; Buratto M; Pelizzo M; Pansini G; Bondanelli M; Ambrosio MR; Degli Uberti EC
    Anal Cell Pathol (Amst); 2010; 33(5):207-16. PubMed ID: 20978326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cholecystokinin2-receptor mediates calcitonin secretion, gene expression, and proliferation in the human medullary thyroid carcinoma cell line, TT.
    Bläker M; Arrenberg P; Stange I; Schulz M; Burghardt S; Michaelis H; Pace A; Greten H; von Schrenck T; de Weerth A
    Regul Pept; 2004 Apr; 118(1-2):111-7. PubMed ID: 14759564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of intracellular calcitonin gene transcripts in human medullary thyroid carcinoma (MTC) by in situ hybridization.
    Noel M; Gavoille A; Lasmoles F; Kahn E; Caillou B; Gardet P; Fragu P
    J Endocrinol Invest; 1990; 13(7):567-73. PubMed ID: 2229929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor capacity of a dominant-negative RET proto-oncogene mutant in a medullary thyroid carcinoma model.
    Drosten M; Stiewe T; Pützer BM
    Hum Gene Ther; 2003 Jul; 14(10):971-82. PubMed ID: 12869215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion.
    Freichel M; Zink-Lorenz A; Holloschi A; Hafner M; Flockerzi V; Raue F
    Endocrinology; 1996 Sep; 137(9):3842-8. PubMed ID: 8756555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
    Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
    J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nodal metastasis microRNA expression correlates with the primary tumour in MTC.
    Gundara JS; Zhao JT; Gill AJ; Clifton-Bligh R; Robinson BG; Delbridge L; Sidhu SB
    ANZ J Surg; 2014 Apr; 84(4):235-9. PubMed ID: 23072640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression.
    Cvejic D; Savin S; Golubovic S; Paunovic I; Tatic S; Havelka M
    Histopathology; 2000 Dec; 37(6):530-5. PubMed ID: 11122435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Atypical" medullary thyroid carcinoma with little or no calcitonin expression.
    Schmid KW; Ensinger C
    Virchows Arch; 1998 Sep; 433(3):209-15. PubMed ID: 9769123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.
    Yang X; Liu G; Xiao H; Yu F; Xiang X; Lu Y; Li W; Liu X; Li S; Shi Y
    Pathol Oncol Res; 2014 Jul; 20(3):641-8. PubMed ID: 24488334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta 1 induces growth inhibition of a human medullary thyroid carcinoma cell line despite an increase in steady state c-myc messenger ribonucleic acid levels.
    Khosla S; Oursler MJ; Schroeder MJ; Eberhardt NL
    Endocrinology; 1994 Nov; 135(5):1887-93. PubMed ID: 7956909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets.
    Abraham D; Jackson N; Gundara JS; Zhao J; Gill AJ; Delbridge L; Robinson BG; Sidhu SB
    Clin Cancer Res; 2011 Jul; 17(14):4772-81. PubMed ID: 21622722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen receptor expression in C-cells and in medullary thyroid carcinoma.
    Zhai QH; Ruebel K; Thompson GB; Lloyd RV
    Endocr Pathol; 2003; 14(2):159-65. PubMed ID: 12858007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family members of patients with sporadic medullary thyroid carcinoma must be screened for hereditary disease.
    Olson JE; Hughes J; Alpern HD
    Surgery; 1992 Dec; 112(6):1074-8; discussion 1078-9. PubMed ID: 1455309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma.
    Pacini F; Fontanelli M; Fugazzola L; Elisei R; Romei C; Di Coscio G; Miccoli P; Pinchera A
    J Clin Endocrinol Metab; 1994 Apr; 78(4):826-9. PubMed ID: 8157706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular forms of trefoil factor 1 in normal gastric mucosa and its expression in normal and abnormal gastric tissues.
    Ren JL; Luo JY; Lu YP; Wang L; Shi HX
    World J Gastroenterol; 2006 Dec; 12(45):7361-4. PubMed ID: 17143957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma.
    Cascon A; Cebrian A; Pollan M; Ruiz-Llorente S; Montero-Conde C; Leton R; Gutierrez R; Lesueur F; Milne RL; Gonzalez-Albarran O; Lucas-Morante T; Benitez J; Ponder BA; Robledo M
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2127-30. PubMed ID: 15623805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
    Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
    World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.